Patient demographics in the pathology study
| Non-HFE (n=11) | HFE (n=11) | P value | |
| Mean age, years±SD | 61.55±4.01 | 61.36±7.97 | 0.947 |
| Sex | 1.000 | ||
| Male | 9 | 9 | |
| Female | 2 | 2 | |
| BCLC stage | 0.311 | ||
| 0 | 1 | 0 | |
| A | 7 | 10 | |
| B | 3 | 1 | |
| Locoregional therapy | 0.361 | ||
| Yes | 5 | 2 | |
| No | 6 | 9 | |
| Lymphovascular invasion | 0.387 | ||
| Yes | 3 | 6 | |
| No | 8 | 5 | |
| Tumour differentiation | 0.805 | ||
| Well | 4 | 2 | |
| Moderate | 6 | 8 | |
| Poor | 1 | 1 | |
| Cirrhosis | 0.635 | ||
| Yes | 9 | 7 | |
| No | 2 | 4 | |
| Tumour number | 1.000 | ||
| Single | 6 | 6 | |
| Multiple | 5 | 5 | |
| Largest tumour size (cm) | 0.431 | ||
| Median | 3.7 | 3.5 | |
| Range | 0.7–7 | 2–14 | |
| Tumour aggregate diameter (cm) | 0.216 | ||
| Median | 4.5 | 5.8 | |
| Range | 0.7–8.9 | 2–15.5 | |
| AFP (kU/L) | 0.381 | ||
| Median | 3.1 | 12.1 | |
| Range | 1–169 | 1.5–720 | |
| Ferritin (µg/L) | 0.062 | ||
| Median | 149.0 | 585.5 | |
| Range | 17–1075 | 58.5–2084 | |
| HFE diagnosis | |||
| Genetic | N/A | 7 | |
| Clinical | N/A | 4 |
AFP, α-fetoprotein; BCLC, Barcelona Clinic Liver Cancer; HFE, haemochromatosis; N/A, not available.